NEOGEN Stock Overview
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Neogen Chemicals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,392.30 |
| 52 Week High | ₹1,859.30 |
| 52 Week Low | ₹1,176.00 |
| Beta | 0.38 |
| 1 Month Change | 11.06% |
| 3 Month Change | -2.78% |
| 1 Year Change | -13.89% |
| 3 Year Change | 58.90% |
| 5 Year Change | n/a |
| Change since IPO | 428.29% |
Recent News & Updates
Recent updates
Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?
Apr 12
Neogen Chemicals (NSE:NEOGEN) Is Increasing Its Dividend To ₹2.75
Aug 11Neogen Chemicals Limited (NSE:NEOGEN) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10Here's Why I Think Neogen Chemicals (NSE:NEOGEN) Is An Interesting Stock
Feb 09Neogen Chemicals' (NSE:NEOGEN) Returns On Capital Not Reflecting Well On The Business
Sep 21Neogen Chemicals' (NSE:NEOGEN) Dividend Will Be Increased To ₹2.25
Sep 05Neogen Chemicals (NSE:NEOGEN) Will Pay A Larger Dividend Than Last Year At ₹2.25
Aug 11Does Neogen Chemicals (NSE:NEOGEN) Deserve A Spot On Your Watchlist?
Jun 04Should You Think About Buying Neogen Chemicals Limited (NSE:NEOGEN) Now?
May 24Neogen Chemicals (NSE:NEOGEN) May Have Issues Allocating Its Capital
Apr 05Is Neogen Chemicals Limited's(NSE:NEOGEN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 07Should You Buy Neogen Chemicals Limited (NSE:NEOGEN) For Its Dividend?
Feb 21
Does Neogen Chemicals (NSE:NEOGEN) Have A Healthy Balance Sheet?
Jan 26Could The Neogen Chemicals Limited (NSE:NEOGEN) Ownership Structure Tell Us Something Useful?
Jan 13The Returns At Neogen Chemicals (NSE:NEOGEN) Provide Us With Signs Of What's To Come
Dec 31Don't Ignore The Fact That This Insider Just Sold Some Shares In Neogen Chemicals Limited (NSE:NEOGEN)
Dec 18Neogen Chemicals Limited (NSE:NEOGEN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Dec 07If You Had Bought Neogen Chemicals (NSE:NEOGEN) Shares A Year Ago You'd Have Earned 70% Returns
Nov 23Shareholder Returns
| NEOGEN | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 0.5% | 1.9% | 1.4% |
| 1Y | -13.9% | 18.9% | 46.1% |
Return vs Industry: NEOGEN underperformed the Indian Chemicals industry which returned 16.5% over the past year.
Return vs Market: NEOGEN underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| NEOGEN volatility | |
|---|---|
| NEOGEN Average Weekly Movement | 4.5% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: NEOGEN has not had significant price volatility in the past 3 months.
Volatility Over Time: NEOGEN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 581 | Haridas Kanani | www.neogenchem.com |
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; and advance intermediates. The company also provides custom synthesis and manufacturing services.
Neogen Chemicals Limited Fundamentals Summary
| NEOGEN fundamental statistics | |
|---|---|
| Market cap | ₹36.73b |
| Earnings (TTM) | ₹330.40m |
| Revenue (TTM) | ₹6.95b |
111.2x
P/E Ratio5.3x
P/S RatioIs NEOGEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEOGEN income statement (TTM) | |
|---|---|
| Revenue | ₹6.95b |
| Cost of Revenue | ₹3.93b |
| Gross Profit | ₹3.02b |
| Other Expenses | ₹2.69b |
| Earnings | ₹330.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.52 |
| Gross Margin | 43.50% |
| Net Profit Margin | 4.75% |
| Debt/Equity Ratio | 96.3% |
How did NEOGEN perform over the long term?
See historical performance and comparison